Ken Griffin Bio Techne Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bio Techne Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 7,200 shares of TECH stock, worth $382,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,200
Previous 33,000
78.18%
Holding current value
$382,608
Previous $2.38 Million
82.24%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding TECH
# of Institutions
628Shares Held
160MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$985 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$796 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$604 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$347 Million0.02% of portfolio
-
Morgan Stanley New York, NY5.72MShares$304 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.08B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...